Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and bupropion, alone and in combination, for treatment of alcohol use disorder
2018-000048-24Phase 2Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of varenicline and bupropion in alcohol use disorder (AUD) (4 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Primary alcohol consumption endpoints. Started Oct 2018; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2018-000048-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000048-24.